Document ID: chunk:federal_register_of_legislation:C2022A00014:clause:2_2
Version: federal_register_of_legislation:C2022A00014
Segment Type: clause
Provision Reference: sch 2 cl 2
Character Range: 7208–8484

2  At the end of Division 25
Add:

25‑125  COVID‑19 tests
 (1) You can deduct a loss or outgoing to the extent it is incurred in gaining or producing your assessable income if:
 (a) you are an individual; and
 (b) the loss or outgoing is incurred in respect of testing you for the novel coronavirus SARS‑CoV‑2 that causes COVID‑19 using a test covered by subsection (3); and
 (c) the purpose of testing you is to determine whether you may attend or remain at a place where you:
 (i) engage in activities to gain or produce your assessable income; or
 (ii) engage in activities in the course of carrying on a *business for the purpose of gaining or producing your assessable income.
 (2) However, you cannot deduct a loss or outgoing under this section to the extent that it is a loss or outgoing of capital, or of a capital nature.
 (3) This subsection covers a test that:
 (a) is a polymerase chain reaction test; or
 (b) is a therapeutic good (within the meaning of the Therapeutic Goods Act 1989) that:
 (i) is included in the Australian Register of Therapeutic Goods maintained under section 9A of that Act; and
 (ii) has an intended purpose, accepted in relation to that inclusion, that relates to the detection of the novel coronavirus SARS‑CoV‑2 that causes COVID‑19.